Tara Bancroft
Stock Analyst at TD Cowen
(2.80)
# 1,600
Out of 5,090 analysts
10
Total ratings
62.5%
Success rate
23.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $12.58 | +58.98% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $63.30 | +26.38% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $30.76 | +62.55% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $89.65 | -27.50% | 1 | Sep 24, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.31 | +663.36% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $96.14 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $7.07 | - | 1 | Aug 31, 2022 |
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $12.58
Upside: +58.98%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $63.30
Upside: +26.38%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $30.76
Upside: +62.55%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $89.65
Upside: -27.50%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.31
Upside: +663.36%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $96.14
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $7.07
Upside: -